San Diego startup Gallant has secured $18 million in funding to develop the first FDA-approved ready-to-use stem cell therapy for veterinary medicine. If successful in regulatory approval, this innovation could revolutionize treatments for pets, marking a significant advancement in the experimental field of stem cell research.
Explain It To Me Like I’m 5: